Secondary Endpoints QUICK-I |
---|
   1. The proportion of patients in whom cardiovascular disease (CVD) risk factor treatment is successful (see definitions) after 1 year of follow up |
   2. The incidence of target organ damage* and established CVD during the study period |
   3. The incidence of all cause mortality during the study period |
   4. Change in the score on the 12-Item Short Form Health Survey quality of life questionnaire at 1 year of follow up compared to baseline |
   5. Change in the score on the 8-item Morisky Medication Adherence Scale measured with 3 month intervals during one year of follow up |
   6. Incidence of side effects of prescribed drugs for CVD prevention, during the follow up period |